Table 4.

Visual Acuity at the Time of RPE Tear and after 12 Months of Continued Anti-VEGF Treatment

Patient	VA at RPE Tear logMAR (Snellen)*	VA after 12 Months of Anti-VEGF logMAR (Snellen)*	Outcome
1	0.6 (20/80)	0.6 (20/80)	Stable
2	1.0 (20/200)	0.84 (20/138)	Improved
3	NA	0.82 (20/132)	Improved
4	0.6 (20/80)	1.0 (20/200)	Worsened
5	1.12 (20/264)	0.96 (20/182)	Improved
6	1.2 (20/320)	0.92 (20/166)	Improved
7	0.8 (20/125)	0.64 (20/87)	Improved

Table reproduced from Empeslidis et al¹²©; Licensee Bentham Open.

^*Conversions of logMAR values to Snellen ratios completed as described in Holladay.⁴¹

logMAR, logarithm of the minimum angle of resolution; NA, not available; VA, visual acuity.